BRIEF published on 10/20/2026 at 08:35, 7 days 22 hours ago Adocia lève 7 millions d'euros pour prolonger sa trésorerie. Financement Augmentation De Capital Biopharmaceutique Prêt D'actionnaire Cash Runway
BRIEF published on 10/20/2026 at 08:35, 7 days 22 hours ago Adocia Secures €7 Million to Extend Cash Runway Financing Capital Increase Biopharmaceutical Shareholder Loan Cash Runway
PRESS RELEASE published on 10/20/2026 at 08:30, 7 days 22 hours ago Informations privilégiées / Autres communiqués Adocia annonce un financement de 7 millions d’euros et l’extension de son horizon de trésorerie à 2028. Augmentation de capital et convention d’avance en compte courant avec Vester Finance Actionnaires Financement Trésorerie ADOCIA Vester Finance
PRESS RELEASE published on 10/20/2026 at 08:30, 7 days 22 hours ago Inside Information / Other news releases ADOCIA secures €7 million financing, extending cash runway to 2028. Capital increase of €3 million and amended shareholder loan agreement with Vester Finance. Financial visibility until 2029 Financing Capital Increase Shareholder Loan Cash Runway ADOCIA
BRIEF published on 06/08/2026 at 07:05, 4 months 20 days ago Adocia's BioChaperone® Lispro: Promising Phase 3 Results Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro Glycemic Control
BRIEF published on 06/08/2026 at 07:05, 4 months 20 days ago ADOCIA présente des résultats prometteurs pour BioChaperone® Lispro Phase 3 Résultats Positifs BioChaperone Lispro Diabète Type 2 Contrôle Glycémique
BRIEF published on 06/08/2026 at 07:05, 4 months 20 days ago ADOCIA presents promising results for BioChaperone® Lispro Positive Results Phase 3 Type 2 Diabetes BioChaperone Lispro Blood Glucose Control
BRIEF published on 06/08/2026 at 07:05, 4 months 20 days ago BioChaperone® Lispro d'Adocia : des résultats prometteurs en phase 3 Diabète De Type 2 Résultats De La Phase 3 BioChaperone® Lispro Contrôle Glycémique Adocie
PRESS RELEASE published on 06/08/2026 at 07:00, 4 months 20 days ago Informations privilégiées / Autres communiqués ADOCIA annonce les résultats de phase 3 de BioChaperone® Lispro pour le diabète de type 2 lors de l'ADA, confirmant les résultats positifs de juillet 2025 Phase 3 Diabète De Type 2 ADOCIA BioChaperone® Lispro ADA
PRESS RELEASE published on 06/08/2026 at 07:00, 4 months 20 days ago Inside Information / Other news releases Adocia announces positive Phase 3 results of BioChaperone® Lispro for type 2 diabetes, presenting superior glycemic control benefits over Humalog® Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro ADA 86th Scientific Session
Published on 10/28/2026 at 02:55, 4 hours 26 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 4 hours 31 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 7 hours 41 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 7 hours 56 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 9 hours 51 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/28/2026 at 07:08, 12 minutes ago EEII AG: EEII AG et Haute Capital Partners SA signent une déclaration d’intention commune non contraignante
Published on 10/28/2026 at 07:08, 12 minutes ago EEII AG: EEII AG and Haute Capital Partners SA sign a joint non-binding declaration of intent
Published on 10/28/2026 at 07:05, 15 minutes ago OLX Group launches Agentic Selling and DealFinder as research shows customers want AI they can trust
Published on 10/28/2026 at 07:05, 15 minutes ago Toyama Prefectural Museum of Art and Design Calls for Entries for 15th International Poster Triennale in Toyama, 2027 (IPT2027)
Published on 10/28/2026 at 07:02, 18 minutes ago PALFINGER AG: PALFINGER sharpens portfolio and risk profile, strengthening focus, profitability and resilience in the third quarter 2026
Published on 10/27/2026 at 18:00, 13 hours 21 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 13 hours 21 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
